Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Top Cited Papers
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9244), 1800-1805
- https://doi.org/10.1016/s0140-6736(00)03232-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hepatitis C Virus in Lymphoid Cells of Patients Coinfected with Human Immunodeficiency Virus Type 1: Evidence of Active Replication in Monocytes/Macrophages and LymphocytesThe Journal of Infectious Diseases, 2000
- Increase in Hepatitis C Virus Load in Hemophiliacs during Treatment with Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.JCI Insight, 1998
- Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- The Association between Hepatitis C Virus Genotype and Human Immunodeficiency Virus Disease Progression in a Cohort of Hemophilic MenThe Journal of Infectious Diseases, 1997
- Interferon for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- High hepatitis C viraemia and impaired antibody response in patients coinfected with HIVAIDS, 1995
- Hepatitis C in Hiv–Infected Patients With and Without Aids: Prevalence and Relationship to Patient SurvivalHepatology, 1994
- Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.BMJ, 1990
- Partial residuals for the proportional hazards regression modelBiometrika, 1982